Polycystic Ovarian Syndrome Clinical Trials

A listing of Polycystic Ovarian Syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 38 clinical trials
Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index (AMLODIP)

Embryo implantation depends on two main factors: embryo grading quality and endometrial receptivity.Numerous tools have been suggested to evaluate these two factors. Measurement of the pulsatility index (PI) of the uterine arteries is associated with extremely low chances of pregnancy when it is high, especially higher than 3. A pilot …

Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
Vitamin D and Pregnancy Outcome in PCOS Patients

This multicenter double-blinded placebo-controlled randomised trial aims to evaluate the effectiveness of vitamin D supplementation prior to IVF on the live birth rate in women with PCOS. Women

vitamin
  • 69 views
  • 04 Oct, 2022
  • 2 locations
Inositol Supplementation to Treat Polycystic Ovary Syndrome: A Double Blind Dose Ranging RCT (INSUPP-PCOS) (INSUPP-PCOS)

To determine if Inositol, a dietary supplement, will improve ovarian and adrenal androgen excess in women with Polycystic Ovarian Syndrome(PCOS).

androgens
free androgen index
testosterone level
anovulation
oligomenorrhea
  • 847 views
  • 23 Oct, 2022
  • 1 location
Effect of Dietary Fiber Intervention on Patients With Polycystic Ovary Syndrome

The purpose of the study is to understand the effect of dietary fiber on patients with polycystic ovary syndrome.

oligomenorrhea
hyperandrogenism
  • 0 views
  • 04 Oct, 2022
  • 1 location
Supporting Understanding of PCOS Education and Research. Official Title: Glycemic Reduction Approaches in Polycystic Ovary Syndrome: a Comparative Effectiveness Study (SUPER)

with polycystic ovary syndrome. Participants will have screening (includes blood draw) and baseline testing with a continuous glucose monitor and a body composition scan (called a dual-energy x

fasting
free androgen index
testosterone level
anovulation
oligomenorrhea
  • 0 views
  • 10 Oct, 2022
  • 1 location
Potential Use of Umbilical Cord Mesenchymal Stem Cells and Secretoms for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.

The purpose of this study is to investigating the effect of Umbilical Cord Mesenchymal Stem Cell (UC-MSCs) and secretomes to insulin resistance in Polycystic Ovary Syndrome (PCOS) patients. This

  • 0 views
  • 19 Oct, 2022
  • 1 location
MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women With Polycystic Ovary Syndrome. (MYPP)

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. PCOS is a heterogeneous condition, characterised by metabolic disturbances, insulin

endocrine disorder
insulin sensitivity
testosterone level
inositol
pcos
  • 0 views
  • 07 Oct, 2022
  • 1 location
A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS) (SPIOMET4HEALTH)

combination of Spironolactone, Pioglitazone and Metformin (SPIOMET) for adolescent girls and young adult women with polycystic ovary syndrome. Study description: Currently, there is no European

anovulation
testosterone level
testosterone
hirsutism
anovulatory
  • 79 views
  • 04 Oct, 2022
  • 3 locations
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

An investigation of the safety and efficacy of tildacerfont in women with PCOS and elevated adrenal androgens

androgens
body mass index
  • 26 views
  • 04 Oct, 2022
  • 7 locations
Treating PCOS With Semaglutide vs Active Lifestyle Intervention

Girls with obesity and polycystic ovarian syndrome will receive either glucagon like peptide-1 receptor agonist therapy or a dietary intervention for 12 weeks to decrease the metabolic syndrome

insulin sensitivity
dietary modification
weight loss diet
receptor agonist therapy
fats
  • 239 views
  • 04 Oct, 2022
  • 1 location